Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

French National Longitudinal Prospective Follow-up of Children Born Small for Gestational Age and Treated With Norditropin SimpleXx (French Health Authorities Commitment)

NCT01578135 is registered in ClinicalTrials.gov with Novo Nordisk A/S as lead sponsor.

NCT NCT01578135
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01578135 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
French National Longitudinal Prospective Follow-up of Children Born Small for Gestational Age and Treated With Norditropin SimpleXx (French Health Authorities Commitment)
Lead sponsor
Novo Nordisk A/S
Phase
Observational
Overall status
Completed
Start date
March 18, 2007
Completion date
October 9, 2018
Enrollment
291 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

growth disorder, small for gestational age